Procedural efficacy and complications of X-Sizer thrombectomy in de novo and stented lesions

Gordon E. Pate; Robert Lowe; Arun Kuchela; Christopher E. Buller; Sanjeev Vaderah; Ronald G. Carere; Donald R. Ricci; Jaap N. Hamburger; John G. Webb

doi:10.1002/ccd.20109

Procedural efficacy and complications of X-Sizer thrombectomy in de novo and stented lesions

Gordon E. Pate, Robert Lowe, Arun Kuchela, Christopher E. Buller, Sanjeev Vaderah, Ronald G. Carere, Donald R. Ricci, Jaap N. Hamburger, John G. Webb

Research output: Contribution to journal › Article

10 Scopus citations

Abstract

Angiographic thrombus is associated with poorer procedural and clinical outcomes. We report our experience with the X-Sizer thrombectomy device (EndiCOR Medical) from March 2001 to December 2002. Indications for use in 44 patients (33 male; mean age, 60) included myocardial infarction (27), unstable angina (6), periprocedural thrombosis (2), acute (< 24 hr) stent thrombosis (1), and subacute (> 24 hr) stent thrombosis (8). Three cases involved vein grafts. Deployment was successful in 42/44. Difficulty traversing the stent occurred in 5/9 cases of in-stent thrombosis. Median TIMI flow increased from 1 to 2 (P = 0.01) postthrombectomy. Median final TIMI flow was 3. Complications included dissection (1), perforation, device jam on stent (1), disruption of a covered stent (1), distal macro-embolization (4), and transient no-reflow (5). The X-Sizer thrombectomy device improves TIMI flow but does not always prevent distal embolization. Care is needed when treating in-stent thrombosis.

Original language	English (US)
Pages (from-to)	177-182
Number of pages	6
Journal	Catheterization and Cardiovascular Interventions
Volume	63
Issue number	2
DOIs	https://doi.org/10.1002/ccd.20109
State	Published - Oct 1 2004

Keywords

Coronary
Stent
Vein graft

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging
Cardiology and Cardiovascular Medicine

Access to Document

10.1002/ccd.20109

Fingerprint Dive into the research topics of 'Procedural efficacy and complications of X-Sizer thrombectomy in de novo and stented lesions'. Together they form a unique fingerprint.

Cite this

Pate, G. E., Lowe, R., Kuchela, A., Buller, C. E., Vaderah, S., Carere, R. G., Ricci, D. R., Hamburger, J. N., & Webb, J. G. (2004). Procedural efficacy and complications of X-Sizer thrombectomy in de novo and stented lesions. Catheterization and Cardiovascular Interventions, 63(2), 177-182. https://doi.org/10.1002/ccd.20109

Procedural efficacy and complications of X-Sizer thrombectomy in de novo and stented lesions. / Pate, Gordon E.; Lowe, Robert; Kuchela, Arun; Buller, Christopher E.; Vaderah, Sanjeev; Carere, Ronald G.; Ricci, Donald R.; Hamburger, Jaap N.; Webb, John G.

In: Catheterization and Cardiovascular Interventions, Vol. 63, No. 2, 01.10.2004, p. 177-182.

Research output: Contribution to journal › Article

@article{6737f2b50f5c4bb4a3b483a348659d59,

title = "Procedural efficacy and complications of X-Sizer thrombectomy in de novo and stented lesions",

abstract = "Angiographic thrombus is associated with poorer procedural and clinical outcomes. We report our experience with the X-Sizer thrombectomy device (EndiCOR Medical) from March 2001 to December 2002. Indications for use in 44 patients (33 male; mean age, 60) included myocardial infarction (27), unstable angina (6), periprocedural thrombosis (2), acute (< 24 hr) stent thrombosis (1), and subacute (> 24 hr) stent thrombosis (8). Three cases involved vein grafts. Deployment was successful in 42/44. Difficulty traversing the stent occurred in 5/9 cases of in-stent thrombosis. Median TIMI flow increased from 1 to 2 (P = 0.01) postthrombectomy. Median final TIMI flow was 3. Complications included dissection (1), perforation, device jam on stent (1), disruption of a covered stent (1), distal macro-embolization (4), and transient no-reflow (5). The X-Sizer thrombectomy device improves TIMI flow but does not always prevent distal embolization. Care is needed when treating in-stent thrombosis.",

keywords = "Coronary, Stent, Vein graft",

author = "Pate, {Gordon E.} and Robert Lowe and Arun Kuchela and Buller, {Christopher E.} and Sanjeev Vaderah and Carere, {Ronald G.} and Ricci, {Donald R.} and Hamburger, {Jaap N.} and Webb, {John G.}",

year = "2004",

month = oct,

day = "1",

doi = "10.1002/ccd.20109",

language = "English (US)",

volume = "63",

pages = "177--182",

journal = "Catheterization and Cardiovascular Interventions",

issn = "1522-1946",

publisher = "Wiley-Liss Inc.",

number = "2",

}

TY - JOUR

T1 - Procedural efficacy and complications of X-Sizer thrombectomy in de novo and stented lesions

AU - Pate, Gordon E.

AU - Lowe, Robert

AU - Kuchela, Arun

AU - Buller, Christopher E.

AU - Vaderah, Sanjeev

AU - Carere, Ronald G.

AU - Ricci, Donald R.

AU - Hamburger, Jaap N.

AU - Webb, John G.

PY - 2004/10/1

Y1 - 2004/10/1

N2 - Angiographic thrombus is associated with poorer procedural and clinical outcomes. We report our experience with the X-Sizer thrombectomy device (EndiCOR Medical) from March 2001 to December 2002. Indications for use in 44 patients (33 male; mean age, 60) included myocardial infarction (27), unstable angina (6), periprocedural thrombosis (2), acute (< 24 hr) stent thrombosis (1), and subacute (> 24 hr) stent thrombosis (8). Three cases involved vein grafts. Deployment was successful in 42/44. Difficulty traversing the stent occurred in 5/9 cases of in-stent thrombosis. Median TIMI flow increased from 1 to 2 (P = 0.01) postthrombectomy. Median final TIMI flow was 3. Complications included dissection (1), perforation, device jam on stent (1), disruption of a covered stent (1), distal macro-embolization (4), and transient no-reflow (5). The X-Sizer thrombectomy device improves TIMI flow but does not always prevent distal embolization. Care is needed when treating in-stent thrombosis.

AB - Angiographic thrombus is associated with poorer procedural and clinical outcomes. We report our experience with the X-Sizer thrombectomy device (EndiCOR Medical) from March 2001 to December 2002. Indications for use in 44 patients (33 male; mean age, 60) included myocardial infarction (27), unstable angina (6), periprocedural thrombosis (2), acute (< 24 hr) stent thrombosis (1), and subacute (> 24 hr) stent thrombosis (8). Three cases involved vein grafts. Deployment was successful in 42/44. Difficulty traversing the stent occurred in 5/9 cases of in-stent thrombosis. Median TIMI flow increased from 1 to 2 (P = 0.01) postthrombectomy. Median final TIMI flow was 3. Complications included dissection (1), perforation, device jam on stent (1), disruption of a covered stent (1), distal macro-embolization (4), and transient no-reflow (5). The X-Sizer thrombectomy device improves TIMI flow but does not always prevent distal embolization. Care is needed when treating in-stent thrombosis.

KW - Coronary

KW - Stent

KW - Vein graft

UR - http://www.scopus.com/inward/record.url?scp=4744348333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4744348333&partnerID=8YFLogxK

U2 - 10.1002/ccd.20109

DO - 10.1002/ccd.20109

M3 - Article

C2 - 15390253

AN - SCOPUS:4744348333

VL - 63

SP - 177

EP - 182

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

SN - 1522-1946

IS - 2

ER -